Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Moritz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Endocrinology|May 31, 2013
Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementiaMark B Zimering, Thomas E Moritz, Robert J Donnelly
Metabolism: Clinical and Experimental|February 17, 2009
Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Thomas E Moritz, et al.
Metabolism: Clinical and Experimental|March 9, 2010
Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitusMark B Zimering, Robert J Anderson, Ling Ge, et al.
Metabolism: Clinical and Experimental|October 23, 2008
Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Ping Luo, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Thomas E Moritz, et al.
Frontiers in Endocrinology|December 10, 2013
Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trialMark B Zimering, Robert J Anderson, Ling Ge, et al.
Diabetes Care|November 10, 2010
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes TrialRobert J Anderson, Gideon D Bahn, Thomas E Moritz, et al.
Diabetes Care|September 3, 2010
Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT)Aramesh Saremi, Thomas E Moritz, Robert J Anderson, et al.
Atherosclerosis|September 23, 2008
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)Aramesh Saremi, Robert J Anderson, Ping Luo, et al.
The American Journal of Cardiology|November 3, 2004
Disparate opinions regarding indications for coronary artery revascularization before elective vascular surgeryGordon L Pierpont, Thomas E Moritz, Steven Goldman, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Endocrinology|May 31, 2013
Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementiaMark B Zimering, Thomas E Moritz, Robert J Donnelly
Metabolism: Clinical and Experimental|February 17, 2009
Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Thomas E Moritz, et al.
Metabolism: Clinical and Experimental|March 9, 2010
Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitusMark B Zimering, Robert J Anderson, Ling Ge, et al.
Metabolism: Clinical and Experimental|October 23, 2008
Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Ping Luo, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes TrialMark B Zimering, Robert J Anderson, Thomas E Moritz, et al.
Frontiers in Endocrinology|December 10, 2013
Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trialMark B Zimering, Robert J Anderson, Ling Ge, et al.
Diabetes Care|November 10, 2010
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes TrialRobert J Anderson, Gideon D Bahn, Thomas E Moritz, et al.
Diabetes Care|September 3, 2010
Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT)Aramesh Saremi, Thomas E Moritz, Robert J Anderson, et al.
Atherosclerosis|September 23, 2008
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)Aramesh Saremi, Robert J Anderson, Ping Luo, et al.
The American Journal of Cardiology|November 3, 2004
Disparate opinions regarding indications for coronary artery revascularization before elective vascular surgeryGordon L Pierpont, Thomas E Moritz, Steven Goldman, et al.
Pageof 3